SCHEMBL48628

SCHEMBL48628

O=C(COCCc1ccc2sccc2c1)CN1CC(O)C1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.68
CYP2A6 P11509 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
KCNH2 Q12809 1/20 0.33
MCHR2 Q969V1 1/20 0.33
MCHR1 Q99705 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.32
CTNNB1 P35222 1/20 0.32
WNT3A P56704 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
LTA4H P09960 1/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48003 0.84 SIGMAR1 (0.64) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
SCHEMBL27025 0.83 SIGMAR1 (0.91) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
SCHEMBL6617776 0.83 SIGMAR1 (0.49) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
Hydrochloric Acid SCHEMBL47954 0.82 SIGMAR1 (0.89) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
T-817 SCHEMBL30574118 0.81 SIGMAR1 (1.00) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
T-817 SCHEMBL27725 0.81 SIGMAR1 (1.00) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
T-817 SCHEMBL47926 0.80 SIGMAR1 (0.98) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
SCHEMBL47940 0.80 SIGMAR1 (0.58) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
T-817 SCHEMBL4134384 0.79 SIGMAR1 (0.86) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1
SCHEMBL47836 0.79 SIGMAR1 (0.66) SIGMAR1CYP2A6OPRM1OPRK1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129535-B2 Alkyl ether derivatives or salts thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-8129535-B2 Alkyl ether derivatives or salts thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-20090111992-A1 ALKYL ETHER DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-30 US disclosed
US-20090111992-A1 ALKYL ETHER DERIVATIVES OR SALTS THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111992-A1 ALKYL ETHER DERIVATIVES OR SALTS THEREOF AHNAK, NGF, PMP22 SIGMAR1 1934/4885CYP2A6 3512/4885OPRM1 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.